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OBJECTIVES We investigated the midterm clinical significance of human coronary atherosclerotic plaques
temperature after a successful percutaneous coronary intervention.
BACKGROUND Previous studies have shown an increased temperature in human atherosclerotic plaques.
However, the prognostic significance of atherosclerotic plaque temperature in patients
undergoing a successful percutaneous intervention is unknown.
METHODS We prospectively investigated the relation between the temperature difference (DT) between
the atherosclerotic plaque and the healthy vessel wall and event-free survival among 86
patients undergoing a successful percutaneous intervention. Temperature was measured by a
thermography catheter, as previously validated. The study group consisted of patients with
effort angina (EA) (34.5%), unstable angina (UA) (34.5%) and acute myocardial infarction
(AMI) (30%).
RESULTS The DT increased progressively from EA to AMI (0.132 6 0.18°C in EA, 0.637 6 0.26°C
in UA and 0.942 6 0.58°C in AMI). The median clinical follow-up period was 17.88 6 7.16
months. The DT was greater in patients with adverse cardiac events than in patients without
events (DT: 0.939 6 0.49°C vs. 0.428 6 0.42°C; p , 0.0001). The DT was a strong predictor
of adverse cardiac events during the follow-up period (odds ratio 2.14, p 5 0.043). The
threshold of the DT value, above which the risk for an adverse cardiac event was significantly
increased, was 0.5°C. The incidence of adverse cardiac events in patients with DT $0.5°C was
41%, as compared with 7% in patients with DT ,0.5°C (p , 0.001).
CONCLUSIONS Increased local temperature in atherosclerotic plaques is a strong predictor of an unfavorable
clinical outcome in patients with coronary artery disease undergoing percutaneous interven-
tions. (J Am Coll Cardiol 2001;37:1277–83) © 2001 by the American College of Cardiology
Previous studies have revealed in vivo thermal heterogeneity
within human atherosclerotic plaques (1–3). Thermal het-
erogeneity within the atherosclerotic plaques was shown in
20%, 40% and 67% of the patients with stable angina (SA),
unstable angina (UA) and acute myocardial infarction
(AMI), respectively, whereas no heterogeneity was shown in
the control subjects. Ex vivo studies have shown that heat is
released by activated inflammatory cells in the atheroscle-
rotic plaques of the carotid arteries (4). Moreover, temper-
ature correlated positively with cell density and mainly with
the density of macrophages (4).
Furthermore, recent studies have shown that inflamma-
tory cells such as macrophages and T lymphocytes are
present in the majority of restenotic lesions of patients
presenting with UA after a percutaneous intervention (5). In
contrast, the smooth muscle cell area is similar in the
restenotic lesions of patients with SA or UA (5). Thus,
inflammation may lead to destabilization of atherosclerotic
plaques after percutaneous interventions. However, in-
creased plaque temperature associated with acute-phase
reactants expresses an aggressive inflammation (3). Accord-
ingly, the identification of lesions with increased tempera-
ture may indicate the lesions that are predisposed to future
alterations of plaque morphology, producing adverse cardiac
events.
The impact of increased local temperature of atheroscle-
rotic plaques on clinical events after percutaneous coronary
balloon angioplasty is unknown, however. The present study
evaluated the mid-term clinical significance of the temper-
ature of human coronary atherosclerotic plaques after a
successful percutaneous intervention.
METHODS
Study group. The study group consisted of 86 patients.
Inclusion criteria were a single lesion ,20 mm in length in
a major native coronary artery and a proximal reference
vessel diameter $2.5 mm. Thirty patients had effort angina
(EA). Thirty patients with UA were unresponsive to max-
imal medical treatment after a two-day hospital period. In
addition, 26 patients had AMI in which primary angioplasty
was performed within 6 h after the onset of pain.
Patients medicated with corticosteroids or nonsteroidal
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anti-inflammatory drugs, except for aspirin, were excluded
from the study. Moreover, patients with an intercurrent
inflammatory or neoplastic condition likely to be associated
with an acute-phase response were not enrolled in the study.
Exclusion criteria also included multivessel disease and
myocardial infarction less than one month before the
intervention.
The study was performed between November 1998 and
January 1999 at the Department of Cardiology, Athens
Medical School, Athens, Greece. Baseline demographic and
procedural variables were recorded and entered prospec-
tively in a prespecified data base. The study protocol was
approved by the institutional Ethics Committee, and each
patient provided written, informed consent.
Thermography catheter. The design and construction
characteristics of the coronary thermography catheter (3F
diameter), which was developed in our institution, have
been previously described in detail (1–3). In brief, the
technical characteristics of the polyamide thermistor include
1) temperature accuracy of 0.05°C; 2) time constant of
300 ms; 3) spatial resolution of 0.5 mm; and 4) linear
correlation of resistance versus temperature over the range
of 33 to 43°C (1–3).
Procedure. The culprit lesion of interest was outlined in
two or more well-opacified views with biplane angiography.
These projections were obtained before and after the pro-
cedure. A computer-assisted analysis system was used for
quantitative coronary angiography (DCI-S, Automated
Coronary Analysis, Philips, The Netherlands). Automated
edge-detection of the minimal lumen diameter and refer-
ence diameter were measured by use of the guiding catheter
filled with contrast agents as a scaling factor. Moreover, an
intravascular ultrasound (IVUS) catheter (20-MHz; Visions
Five-64 F/XTM Endosonics Corp., Rancho Cordoba, Cal-
ifornia) was introduced to the target vessel for detailed
mapping of the area of interest. Thereafter, patients under-
went percutaneous balloon angioplasty using standard tech-
nique (6). The balloon was dilated with a mixture of
contrast medium and normal saline at 37°C. Procedural
success was defined as final diameter stenosis ,50% and
Thombolysis In Myocardial Infarction (TIMI) flow grade 3.
Subsequently, IVUS examination was repeated to exclude
residual thrombus in patients with thrombus-containing
lesions and to guide selection of healthy, without even small
atheromatous plaques, and diseased segments where tem-
perature measurements were planned to be performed. All
patients received preprocedural aspirin and periprocedural
heparin.
Thus, 5 min after contrast injection, the thermography
catheter was advanced through the guiding catheter, and
blood temperature was measured when the thermistor had
just emerged from the tip of the guiding catheter without
being in contact with the vessel wall. Thereafter, tempera-
ture measurements were made at five locations over a length
of ;1 cm of the normal vessel wall proximal to the lesion.
The most frequent temperature of these locations was
designated as the background temperature. In addition,
measurements were performed at five different lesion sites at
the region of interest (ROI). The coronary segments in
which the temperature was measured were guided by IVUS
findings. Accordingly, the temperature difference (DT) be-
tween the atherosclerotic plaque and the healthy vessel wall
was calculated by subtracting the background temperature
from the maximal temperature at the ROI.
After temperature measurements, deployment of stents
was scheduled in all lesions to achieve optimal long-term
results (7). All operators had no knowledge of the temper-
ature measurements. Optimal stent expansion was defined
as residual diameter stenosis ,10% by quantitative coronary
angiography. All patients were discharged from the hospital
with ticlopidine, aspirin, statin and standard medical therapy.
Clinical follow-up. All patients were prospectively fol-
lowed for the occurrence of the following adverse events: 1)
in-hospital repeat myocardial infarction, recurrent angina
and death. Reinfarction was diagnosed on the basis of the
recurrence of persistent ischemic chest pain followed by at
least two-fold re-elevation of creatine kinase from the last
measured value. Any recurrent chest pain that was accom-
panied by ST-T segment changes on the electrocardiogram
was considered as recurrent angina if reinfarction was ruled
out. 2) Long-term follow-up: the patients without in-
hospital complications were followed periodically in our
outpatient clinic, or they were serially interviewed by tele-
phone at a mean of 17.88 6 7.16 months. All patients
underwent a treadmill stress test at three and six months and
annually after the implantation. Patients with recurrence of
symptoms or a positive treadmill stress test were scheduled
for repeat angiography. The long-term occurrence of recur-
rent angina, myocardial infarction and death was recorded.
For recurrent angina and myocardial infarction, we used the
same definitions for in-hospital events.
Statistical analysis. All data are presented as the mean
value 6 SD. Univariate analysis was based on regression
models, exact chi-square tests and Wilcoxon and Mann-
Whitney criteria. Multivariate and exact logistic regression
analyses were applied to assess the relation of DT with the
adverse cardiac event, adjusted for several cofactors. A Cox
proportional hazards model was applied to estimate the
corresponding relative risk (i.e., odds ratio [OR]) and the
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
DT 5 temperature difference
AUC 5 area under the curve
EA 5 effort angina
IVUS 5 intravascular ultrasound
OR 5 odds ratio
ROC 5 receiver-operating characteristics
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UA 5 unstable angina
1278 Stefanadis et al. JACC Vol. 37, No. 5, 2001
Plaque Temperature After Percutaneous Intervention April 2001:1277–83
relationship between survival and explanatory variables. All
risk factors were tested for pairwise interactions. The main
risk factor (DT) was adjusted for age, treated vessels, total
cholesterol, diabetes mellitus, current smoking, hyperten-
sion, left ventricular dysfunction, previous myocardial in-
farction, acute coronary syndromes (UA and AMI), refer-
ence diameter and minimal lumen diameter. Left ventricular
dysfunction was defined as ejection fraction ,40%.
Sensitivity and specificity values and receiver-operating
characteristics (ROC) curves were calculated to estimate the
crucial threshold (cut-off point) of DT. To evaluate the
diagnostic ability of the method, we calculated the area
under the curve, and we examined its significance with the
Wilcoxon criterion. A p value ,0.05 was considered signif-
icant on univariate analysis, and p , 0.10 was considered
significant on multivariate survival analysis. The analyses
were performed with SPSS, release 8 (SPSS Inc., Chicago,
Illinois), LogXact (Cytel Corp.) and STATA release 6
(STATA Corp., Lakeway Drive, Texas) statistical software
programs.
RESULTS
The demographic characteristics of the study group (n 5
86) are demonstrated in Table 1. There were no differences
between the subgroups of patients with respect to baseline
clinical characteristics. In all patients, the balloon angio-
plasty procedure was successful by achieving final diameter
stenosis ,50% and mechanical lysis of the thrombus in
patients with thrombus-containing lesions. In 82 patients,
82 metallic stents were implanted after completing the
temperature measurements. In all stented segments, optimal
expansion was performed. In four patients, the stents could
not be delivered to the target lesion due to tortuosity of the
coronary vessel.
Procedural temperature measurements. The five mea-
surements obtained for determination of background tem-
perature were constant in each patient of the total study
group, varying by only 0.05°C, with a standard deviation for
each of the patients ranging from 0 to 0.0312. The tem-
perature of the blood and healthy vessel wall did not differ
(p 5 0.45). The DT was similar between patients receiving
aspirin or statin treatment before the percutaneous inter-
vention and those patients who did not receive such med-
ications (p 5 NS, respectively). The DT was significantly
different between the subgroups of the study. In the patients
with EA, DT was 0.132 6 0.18°C; in patients with UA, it
was 0.637 6 0.26°C; and patients with AMI, it was 0.942 6
0.58°C (p , 0.01) (Fig. 1).
Predictive value of DT on event-free survival. In-
hospital complications were observed in four patients. Two
of them had UA and two had AMI. Three of these patients
died, and one patient with UA had a subacute thrombosis.
No statistical significance was observed between the three
subgroups. The remainder of the patients were discharged
from the hospital with no adverse events.
After a median follow-up period of 17.88 6 7.16 months,
17 more patients had an event. Thus, in total, 21 patients of
the whole study group had an adverse cardiac event. Of
them, 4 (13%) had EA, 8 (27%) had UA and 9 (35%) had
AMI (p , 0.01). Three patients died after discharge from
the hospital. Of them, one patient had a fatal AMI and two
had a sudden death. Two patients had AMI, five had UA,
four had SA and three had a positive treadmill stress test. In
these patients, the repeat angiogram revealed restenosis of
the treated vessel. The DT was greater in patients with
adverse cardiac events than in patients without events (DT:
0.939 6 0.49 [first quartile: 0.57, median quartile: 0.87,
third quartile: 1.15] vs. 0.428 6 0.42°C [first quartile: 0.07,
Table 1. Demographic and Angiographic Characteristics of
Study Group (n 5 86)
Age (yrs) 61 6 9
Aspirin use 24 (28%)
Statin use 20 (17%)
Hypertension 39 (45%)
LV dysfunction 26 (30%)
Diabetes 24 (28%)
Total cholesterol (mg/dl) 229 6 37
Smoking 48 (56%)
Previous MI 22 (25%)
Target vessel
LAD 36 (42%)
LCx 13 (15%)
RCA 34 (40%)
SVG 3 (3%)
RD (mm) 2.94 6 0.4
MLD before intervention (mm) 0.94 6 0.5
MLD after intervention (mm) 2.87 6 0.4
Data are presented as the mean value 6 SD or number (%) of patients.
LAD 5 left anterior descending coronary artery; LCx 5 left circumflex coronary
artery; LV 5 left ventricular; MI 5 myocardial infarction; MLD 5 minimal lumen
diameter; RCA 5 right coronary artery; RD 5 reference diameter; SVG 5 saphenous
vein graft.
Figure 1. Difference in atherosclerotic plaque temperature from back-
ground temperature (DT) in the three subgroups. Temperature differences
increase progressively from effort angina (EA) to acute myocardial infarc-
tion (AMI). The bottom of the box represents the first quartile; the top of
the box represents the third quartile; and the line in the box represents the
median value of DT. UA 5 unstable angina.
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median quartile: 0.26, third quartile: 0.70]; p , 0.0001)
(Fig. 2). Moreover, DT was greater in the patients with EA
and UA with adverse cardiac events as compared with those
without events (Table 2) (Fig. 3). In patients with AMI, DT
was greater, although this difference did not reach signifi-
cant statistical difference. Cox regression analysis after
adjustment for age, treated vessels, total cholesterol, diabe-
tes mellitus, current smoking, hypertension, left ventricular
dysfunction, previous myocardial infarction, acute coronary
syndrome, reference diameter and minimal lumen diameter
revealed that DT was a strong predictor of adverse cardiac
events during the follow-up period (OR 2.14, 95% confi-
dence interval 1.31 to 6.85, p 5 0.043). In addition, left
ventricular dysfunction, age, current smoking, minimal
lumen diameter after the procedure and acute coronary
syndrome were also predictors of an adverse cardiac event.
(Table 3). However, the interactions between the covariates
and the main factor of the analysis (DT) were not statisti-
cally significant.
Sensitivity and specificity analyses showed that the
threshold of the DT value (cut-off point) above which the
risk for an adverse outcome after the intervention was
significantly increased, was 0.5°C (ROC area 5 77%) (Fig.
4) (8). The sensitivity for this cut-off point was 86% (18 of
21 patients), and the specificity was 60%. We categorized
the study group into those with DT $0.5°C and those with
DT ,0.5°C. The incidence of adverse cardiac events in
patients with DT $0.5°C was 41%, as compared with 7%
in patients with DT ,0.5°C (p , 0.001). A Cox survival
plot adjusted for DT and stratified for the cut-off point
showed a clear relationship between DT and event-free
survival (Fig. 5).
DISCUSSION
The present study demonstrated that after a successful
percutaneous intervention, DT was a strong predictor of
adverse cardiac events. Moreover, mean DT was greater in
patients with adverse cardiac events within each subgroup,
although in patients with AMI, a trend was found without
achieving statistical significance. The threshold of the DT
value above which the rate of adverse cardiac events was
significantly increased was 0.5°C. The observed differences
were significant and maintained at follow-up. According to
these results, heat release from human coronary atheroscle-
rotic plaques after a successful percutaneous intervention
was associated with an adverse clinical outcome during a
mid-term follow-up period. The majority of the adverse
Figure 2. Difference in atherosclerotic plaque temperature from back-
ground temperature (DT) between patients with an adverse cardiac event
during the follow-up period and those without an adverse outcome. The
bottom of the box represents the first quartile; the top of the box
represents the third quartile; and the line in the box represents the median
value of DT.
Table 2. Temperature Differences Between Patients With and Those Without Adverse Events
in Each Subgroup
Clinical
Syndrome Status n
Mean DT
(°C) 6 SD
First
Quartile
Median
Quartile
Third
Quartile
p
Value
EA Event-free 26 0.07 6 0.09 0 0.05 0.11 , 0.001
Event 4 0.52 6 0.07 0.46 0.52 0.58
UA Event-free 22 0.56 6 0.23 0.41 0.61 0.77 , 0.01
Event 8 0.84 6 0.24 0.59 0.89 1.02
AMI Event-free 17 0.80 6 0.51 0.42 0.91 1.5 , 0.10
Event 9 1.21 6 0.61 0.83 1.1 1.41
For comparison of temperature difference (DT) values, the Mann-Whitney U test was used.
AMI 5 acute myocardial infarction; EA 5 effort angina; UA 5 unstable angina.
Figure 3. The difference in atheromatous plaque temperature from back-
ground temperature (DT) was greater in patients with effort angina (EA)
and unstable angina (UA) with adverse cardiac events than in patients
without events. In patients with acute myocardial infarction (AMI), DT
was greater in patients with an adverse outcome, although DT did not reach
statistical significance. The bottom of the box represents the first quartile;
the top of the box represents the third quartile; and the line in the box
represents the median value of DT.
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cardiac events were related to restenosis of the treated
lesion. Furthermore, we confirmed previous observations
indicating that DT is increased in unstable syndromes as
compared with EA.
Specific comments. A considerable overlap of plaque tem-
perature between patients with EA and patients with acute
coronary syndromes was observed in previous studies (1–3).
Thus, we enrolled patients with all clinical syndromes to
include all temperature values and to correlate the individual
DT with the clinical outcome, regardless of the clinical
syndrome. Therefore, patients with adverse events had an
increased DT as compared with patients without events
during the follow-up period. In contrast, the treatment of
lesions without an increased DT was associated with a
favorable outcome, regardless of the initial clinical syn-
drome. However, in patients with AMI, although DT
tended to be greater in patients with adverse events than in
those without an event, statistical significance was not
achieved. This finding may be due to the number of patients
participating in this subgroup or the duration of follow-up
period.
A critical question is whether the relationship between
heat release and clinical outcome is due to confounding by
an association of DT with other strong predictors of event-free
survival. Whether DT and these strong prognostic factors share
a common causal pathway still remains unknown. However,
adjustment for all of these factors determines the true relation
between DT and event-free survival, because any interaction
among these covariates was not detected.
Furthermore, the relationship between intake of aspirin
and statins after the procedure and event-free survival in
patients with increased DT could not be determined, be-
cause the whole study group was discharged from the
hospital with these medications. Thus, the effect of statins
on plaque stabilization (9) and on local temperature of the
culprit atherosclerotic plaques is unknown. In addition, the
beneficial effects of aspirin in reducing the risks of a first
myocardial infarction are directly related to high plasma
concentrations of C-reactive protein (10,11). However, in
previous studies, a positive correlation was observed between
DT and concentrations of C-reactive protein and serum
amyloid A (2,3). Thus, the administration of aspirin and
statins may cause the true relationship between DT and
event-free survival to be underestimated.
Potential explanations of clinical outcome associated
with temperature measurements. The exact mechanism
by which heat is generated from the atherosclerotic plaques,
resulting in more adverse events, in unknown. Several
factors may contribute to heat release from the atheroscle-
rotic plaques, which theoretically result in poor prognosis
after percutaneous interventions. It seems that the process
leading to increased temperature precedes plaque rupture
and formation of thrombus. This hypothesis is based on the
considerable overlap of plaque temperature between patients
Figure 4. Receiver-operating characteristics (ROC) graph showing the percentage of correct prediction of events (sensitivity) and the percentage of correct
prediction of no events (specificity) during the follow-up period, as function of the difference in atherosclerotic plaque temperature from background
temperature. According to this curve, we can detect a point on it by the increase in sensitivity, with satisfactory specificity, and then estimate the threshold
value. The closer the ROC curve is to the upper left-hand corner of the graph, the more accurate it is, because the true positive rate is 1 and the false-positive
rate is 0. The area under the ROC curve was 77%.
Table 3. Independent Predictors of Adverse Cardiac Events
Prognostic Variable
Odds
Ratio 95% CI
p
Value
DT 2.14 1.31–6.85 0.04
Age 1.08 1.00–1.15 0.03
Hypertension 1.94 0.65–3.52 0.24
LV dysfunction 3.99 1.29–12.37 0.016
Diabetes 1.04 0.03–1.92 0.94
Total cholesterol 1.01 0.04–2.14 0.64
Current smoking 1.48 0.92–4.16 0.07
ACS 2.24 0.74–6.76 0.06
Previous MI 1.85 0.61–2.64 0.31
RD before intervention 1.35 0.31–0.92 0.43
MLD before intervention 1.03 0.75–1.99 0.34
MLD after intervention 1.43 0.76–3.11 0.09
ACS 5 acute coronary syndromes; CI 5 confidence interval; DT 5 difference of
temperature; other abbreviations as in Table 1.
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with EA and patients with acute coronary syndromes,
indicating that a percentage of patients with clinically stable
angina had plaques with increased risk of ischemic events.
The first study showing thermal heterogeneity in vitro
within atherosclerotic plaques, by Casscells et al. (4), also
demonstrated a relationship between the number of infil-
trated macrophages and thermal heterogeneity. It has been
reported that a fifth of culprit lesions in patients with
chronic SA show features of recent injury and repair, and
inflammation is present in these lesions (12). In another
study, elevated concentrations of acute-phase proteins are
found to be predictors of coronary events in patients with
EA and UA (13). Our results support previous reports
demonstrating that an inflammatory process is involved in
the onset of acute coronary syndromes (14) and is also
present in culprit lesions of patients with EA (13). More-
over, previous studies from our group showed that increased
plaque temperature associated with acute-phase reactants
expresses an aggressive inflammation (3). Thus, inflamma-
tion plays a significant role in heat release from atheroscle-
rotic plaques, leading to destabilization of restenotic lesions
during the follow-up period (5,15). Furthermore, inflam-
matory cells (macrophages, T lymphocytes) are present in
the majority of restenotic lesions of patients presenting with
UA. In contrast, the smooth muscle cell area is similar in the
restenotic lesions of patients with SA or UA (5). This
inflammatory reaction is related to the underlying morphol-
ogy. Thus, the detection of lesions with infiltration of
inflammatory cells during a percutaneous intervention may
indicate the lesions that are predisposed to future alterations
of plaque morphology.
In addition, inflammation is correlated with increased
vascular injury (16). The oversizing of stented segments
leads to injury of the arterial wall, which is associated with
thrombus formation and increased neointimal growth. Ac-
cordingly, stent oversizing may appear to be an undesirable
goal in lesions with chronic inflammation that leads to heat
production, because the rate of restenosis in this subgroup of
patients may be considerably increased.
Study limitations. This study was prospective but obser-
vational. However, the study group was rather small. Nev-
ertheless, the results are significant and were maintained
during the follow-up period. Follow-up angiography was
not performed, except for the majority of patients with
clinical events. Moreover, follow-up angiography could lead
to an increased rate of interventions based only on angio-
graphically demonstrated stenosis at follow-up (17). Despite
these results, repeat angiography in all patients would
provide useful information on the correlation of DT with
the angiographic characteristics of the lesion. This was not
the aim of the present study, however. Also, the results of
this study seem unlikely to be affected by progression of the
disease in other stenoses, because all patients had a single
significant stenosis.
In addition, despite our effort, it was impossible to
eliminate all potential confounding factors. Finally, we
cannot reach the conclusion that the association between
increased temperature and an adverse clinical outcome is
causal. The increase in temperature of atheromatous plaques
may be explained by inflammatory activity. However, the
results of a recent study demonstrated that there is a positive
association between the clinical syndrome and the extent of
inflammation in atherectomy specimens of patients with a
restenotic lesion (5).
Conclusions. The results of this study showed that the
difference in temperature between the atherosclerotic plaque
and the healthy vessel wall is a strong predictor of event-free
survival after a successful percutaneous intervention in
patients with coronary artery disease. This study does not
prove a causal relationship between increased temperature of
the atherosclerotic plaque and adverse cardiac events. Our
results, however, serve as an incentive to consider strategies
to stabilize the atherosclerotic plaques after a percutaneous
coronary intervention.
Figure 5. Estimated survival among the study group according to temperature difference (DT). The risk of an adverse cardiac event in patients with DT
.0.5°C is significantly increased, as compared with that in patients with DT ,0.5°C.
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